PET/CT with the common radiotracer 18F-FDG has been found useful for workups and monitoring of infections in real-world hospitalized patients, according to a study conducted by researchers at Yale and Stanford published Nov. 14. 

An established radiopharmaceutical can now be applied with the FDA’s blessing when symptoms of cognitive decline point to the second most common form of degenerative dementia (after only Alzheimer’s disease).  

Contradicting prior research connecting heavy ordering of diagnostic exams with fear of malpractice charges—aka “defensive medicine”—a new survey shows ED referrers more focused on not harming patients than on not getting sued.

Emergency departments that employ nonphysician practitioners probably improve patient access to timely care. However, these EDs also order 5.3% more imaging than their physician-only counterparts.

RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.

The American Roentgen Ray Society (ARRS), Strategic Radiology and Bracco Diagnostics have separately elevated early- and mid-career radiologists to heightened educational opportunities.

Lyme disease patients treated for “brain fog” may develop compensatory alterations in white matter that show up on MRI and correspond—unexpectedly—with slow but sound cognitive performance.

Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.